Optaflexx™ and Monovet® and Tylovet® and MGA®

Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States

  • Animal drug application 200648
  • Animal drug product ID 8718

What the source publishes

Holder
Huvepharma EOOD
Active ingredients
Melengestrol Acetate Monensin Ractopamine Hydrochloride Tylosin Phosphate
Form
Type A medicated articles to be used in the manufacture of Type C medicated feeds
Routes
Oral
Supply regime
VFD

Names this record is found by

Complete source data
us:fda:animaldrugs:6485:8718
{
  "form": "Type A medicated articles to be used in the manufacture of Type C medicated feeds",
  "name": "Optaflexx™ and Monovet® and Tylovet® and MGA®",
  "holder": "Huvepharma EOOD",
  "routes": [
    "Oral"
  ],
  "smpcUrl": null,
  "marketed": null,
  "useDomain": "veterinary",
  "leafletUrl": null,
  "supplyRegime": "VFD",
  "nativeProduct": {
    "routes": [
      "Oral"
    ],
    "species": {
      "Cattle:699": "Heifers fed in confinement for slaughter"
    },
    "sortOrder": 1,
    "withdrawals": [
      "<p>A withdrawal time has not been established for pre-ruminating calves. Do not use in calves to be processed for veal.<br/></p>"
    ],
    "doseFormName": "Type A medicated articles to be used in the manufacture of Type C medicated feeds",
    "applicationId": null,
    "specifications": "Optaflexx™: 45.4 g/lb (100 g/kg) of ractopamine hydrochloride, Monovet®: 90.7 g/lb of monensin, Tylovet®: 40 g/lb and 100 g/lb of tylosin, and MGA®: 200 mg/lb and 500 mg/lb of melengestrol acetate",
    "proprietaryName": "Optaflexx™ and Monovet® and Tylovet® and MGA®",
    "proprietaryNameId": 8718,
    "statusDescription": "VFD"
  },
  "nativeSummary": {
    "noohDate": null,
    "publishDate": "2020-02-24",
    "sponsorName": "Huvepharma EOOD",
    "applicationId": 6485,
    "applicationType": "A",
    "proprietaryName": "Optaflexx™ and Monovet® and Tylovet® and MGA®\n",
    "applicationNumber": 200648,
    "activeIngredientName": "Melengestrol Acetate\nMonensin\nRactopamine Hydrochloride\nTylosin Phosphate\n",
    "applicationStatusCode": "A",
    "applicationStatusValue": null,
    "voluntaryWithdrawalDate": null
  },
  "targetSpecies": [
    {
      "code": "699",
      "label": "Cattle",
      "native": {
        "key": "Cattle:699",
        "population": "Heifers fed in confinement for slaughter"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Heifers fed in confinement for slaughter",
      "canonicalId": "cattle",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    }
  ],
  "informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
  "ingredientScope": "application-level; no product-specific composition inferred",
  "nativePublishDate": "2020-02-24",
  "sourceDisposition": "reviewed-veterinary-application-product",
  "useDomainEvidence": {
    "basis": "publisher-dataset-scope",
    "field": "sourceId",
    "value": "us.fda.animal-drugs",
    "version": 1,
    "sourceId": "us.fda.animal-drugs"
  },
  "withdrawalPeriods": [
    {
      "native": "<p>A withdrawal time has not been established for pre-ruminating calves. Do not use in calves to be processed for veal.<br/></p>",
      "status": "unparsed"
    }
  ],
  "patientEligibility": "not-assessed",
  "nativeApplicationId": 6485,
  "targetSpeciesStatus": "reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "activeIngredientsText": "Melengestrol Acetate\nMonensin\nRactopamine Hydrochloride\nTylosin Phosphate\n",
  "nativeApplicationType": "A",
  "applicationIngredients": [
    {
      "activeIngredientName": "Ractopamine Hydrochloride",
      "activeIngredientTolerance": "The tolerance for ractopamine hydrochloride (the marker residue) in swine is 0.15 part per million) in liver (target tissue).<P>\r\n\r\nThe tolerance for ractopamine hydrochloride (the marker residue) in cattle is 0.03 part per million in muscle and 0.09 part per million in liver.<P>\r\n\r\nThe tolerance for ractopamine hydrochloride (the marker residue) in turkeys is 0.45 ppm in liver(target tissue) and 0.1 ppm in muscle.<P>\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t"
    },
    {
      "activeIngredientName": "Melengestrol Acetate",
      "activeIngredientTolerance": "A tolerance of 25 parts per billion is established for residues of the parent compound, melengestrol acetate, in fat, of cattle."
    },
    {
      "activeIngredientName": "Monensin",
      "activeIngredientTolerance": "<p>A tolerance of 0.05 part per million is established for negligible residues of monensin in the edible tissues of cattle and goats. A tolerance for residues of monensin in chickens, turkeys and quail is not needed.</p>"
    },
    {
      "activeIngredientName": "Tylosin Phosphate",
      "activeIngredientTolerance": "<p>Tolerances are established for residues of tylosin in edible products of animals as follows:     a.  Chickens and turkeys: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney.     b.  Cattle: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney.     c.   Swine: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney.     d.   Milk: 0.05 part per million (negligible residue).     e.   Eggs: 0.2 part per million (negligible residue).</p>"
    }
  ],
  "nativeApplicationNumber": 200648,
  "nativeProprietaryNameId": 8718,
  "restrictionObservations": [
    {
      "indicationText": "<p>For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.<br/></p>",
      "limitationText": null,
      "populationText": "Heifers fed in confinement for slaughter"
    },
    {
      "indicationText": "<p>For increased rate of weight gain, improved feed efficiency and suppression of estrus (heat).<br/></p>",
      "limitationText": null,
      "populationText": "Heifers fed in confinement for slaughter"
    }
  ],
  "withdrawalPeriodsStatus": "reported-unparsed",
  "publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
  "nativeNoticeOfHearingDate": null,
  "nativeApplicationStatusCode": "A",
  "nativeVoluntaryWithdrawalDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.animal-drugs" \
  --data-urlencode "id=us:fda:animaldrugs:6485:8718"